Analysis
Shifting views on lipid lowering therapy
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3531 (Published 28 July 2010) Cite this as: BMJ 2010;341:c3531
Related articles
- Research Published: 30 June 2009; BMJ 338 doi:10.1136/bmj.b2376
- Analysis Published: 26 January 2011; BMJ 342 doi:10.1136/bmj.c6244
- Editorial Published: 27 November 2013; BMJ 347 doi:10.1136/bmj.f7110
See more
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
- Sixty seconds on . . . flyingBMJ June 10, 2024, 385 q1266; DOI: https://doi.org/10.1136/bmj.q1266
Cited by...
- 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
- 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
- Target cardiovascular risk rather than cholesterol concentration
- Assessing Appropriateness of Lipid Management Among Patients With Diabetes Mellitus: Moving From Target to Treatment
- The Large Social Value Resulting From Use Of Statins Warrants Steps To Improve Adherence And Broaden Treatment
- Three Reasons to Abandon Low-Density Lipoprotein Targets: An Open Letter to the Adult Treatment Panel IV of the National Institutes of Health
- JUPITER seems to be bypassed